83OA phase II study of durvalumab (MEDI4736) for previously treated patients with stage IV squamous NSCLC (SqNSCLC): Lung-MAP Sub-study SWOG S1400A
Papadimitrakopoulou, V., Redman, M.W., Borghaei, H., Waqar, S.N., Robert, F., Kiefer, G.J., McDonough, S., Herbst, R.S., Kelly, K., Gandara, D.R.Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx091.003
Date:
April, 2017
File:
PDF, 45 KB
english, 2017